What to know about cardiac isoenzymes: An update
Publication
, Journal Article
Short, SG; Clements, SD
Published in: Primary Cardiology
January 1, 1993
The judicious use of cardiac isoenzymes can clarify the diagnosis of myocardial infarction (MI), direct other cardiac studies, and prevent unnecessary tests. Elevated creatine kinase-MB (CK-MB) levels confirm that an MI with associated cell death has occurred. Lactic dehydrogenase levels are sometimes useful in evaluating patients who may have had an MI3 or 4 days earlier and whose serum CK levels have returned to normal.
Duke Scholars
Published In
Primary Cardiology
ISSN
0363-5104
Publication Date
January 1, 1993
Volume
19
Issue
11
Start / End Page
55 / 64
Citation
APA
Chicago
ICMJE
MLA
NLM
Short, S. G., & Clements, S. D. (1993). What to know about cardiac isoenzymes: An update. Primary Cardiology, 19(11), 55–64.
Short, S. G., and S. D. Clements. “What to know about cardiac isoenzymes: An update.” Primary Cardiology 19, no. 11 (January 1, 1993): 55–64.
Short SG, Clements SD. What to know about cardiac isoenzymes: An update. Primary Cardiology. 1993 Jan 1;19(11):55–64.
Short, S. G., and S. D. Clements. “What to know about cardiac isoenzymes: An update.” Primary Cardiology, vol. 19, no. 11, Jan. 1993, pp. 55–64.
Short SG, Clements SD. What to know about cardiac isoenzymes: An update. Primary Cardiology. 1993 Jan 1;19(11):55–64.
Published In
Primary Cardiology
ISSN
0363-5104
Publication Date
January 1, 1993
Volume
19
Issue
11
Start / End Page
55 / 64